SEARCH WITHIN CONTENT
Citation Information : Journal of Epileptology. Volume 21, Issue 1, Pages 15-25, DOI: https://doi.org/10.1515/joepi-2015-0002
License : (CC BY 4.0)
Received Date : 05-February-2013 / Accepted: 26-March-2013 / Published Online: 03-April-2013
Introduction. The current knowledge of significance of some neurobiological and clinical variables in the prediction of remission length and seizures reduction in partial epilepsies remains sparse and even controversial.
Aim. The current study has been carried out in order to evaluate the possible relationship between epilepsy forms, gender, focus lateralization and handedness with therapeutic remission and seizures reduction during antiepileptic treatment in persons with partial forms of epilepsy.
Material and methods. One hundred and eight patients were studied. Handedness was evaluated using the Annett’s scale. Focus lateralization was detected by use of the EEG. Of the patients studied temporal lobe epilepsy (TLE) was diagnosed in 61 cases and frontal lobe epilepsy (FLE) in 47 cases. There were 44 men and 64 women, of which 83 were right-handed and 25 were left-handed. A left-sided focus was detected in 59 persons whilst a right-sided focus was noted in 49 persons. MANOVA was used for the analysis of interrelationship between four nominal fixed factors (epilepsy forms, gender, handedness, and focus laterality) and dependent variables of therapeutic remission and percentage seizures reduction.
Results. A favorable prognostic significance of FLE vs TLE was observed. In contrast gender, handedness, and focus laterality had no influence on the dependent variables when analyzed separately. However, when two, three and four independent variables were combined an influence on the dependent variables was observed; and some combinations may be used for prediction purposes of therapeutic remission and percentage in seizure reduction. The FLE in the men with the right-handedness and the left focus (FLE • M • Rh • LF) resulted in the maximal length of therapeutic remission and maximal seizures reduction, while the other combinations have resulted in less favorable treatment results. The TLE • M • Rh • RF and TLE • M • Lh • LF were the worst combinations for the remission length and TLE • Fe • Lh • LF for the seizures reduction.
Conclusions. The current study revealed the significance of combinations of some neurobiological and clinical variables in prediction of therapeutic remission and percent of seizures reduction irrespective of used antiepileptic drugs. These results may be used so as to aid patient selection before drug treatment in order to form the homogenous groups of persons.
Annett M.: A classification of hand preference by association analysis. British Journal of Psychology, 1970, 61: 303–321.
Arzimanoglou A. and Ryvlin P.: Towards a clinically meaningful definition of drug-resistance. In: P. Kahane, A. Berg, W. Lőscher, D. Nordli, E. Perucca (eds), Drug-resistant epilepsies, John Libbey Eurotext, Motrouge 2008, 1–6.
Brodie M.J.: Are drug-resistant and drug-sensitive patients the same? Observations from the Glasgow database. In: P. Kahane, A. Berg, W. Lőscher, D. Nordli, E. Perucca (eds), Drug-resistant epilepsies, John Libbey Eurotext, Montrouge 2008, 17–27.
Elwes R.D.C., Johnson A.L., Shorvon S.D., Reynolds E.H.: The prognosis for seizure control in newly diagnosed epilepsy. N. Engl. J. Med., 1984, 311: 944–947.
Feinstein A.R.: Principles of medical statistics. Chapman & Hall/CRC, Boca Raton 2002, 701.
Geschwind N. and Behan P.: Left-handedness: association with immune disease, migraine, and developmental learning disorder. Proc. National Academy of Sciences, 1982, 79: 5097–5100.
Geschwind N. and Galaburda A.: Cerebral Lateralization. Biological mechanisms, associations and pathology: I. a hypothesis and program for research. Arch. Neurol., 1985a, 42: 428–459.
Geschwind N. and Galaburda A.: Cerebral Lateralization. Biological mechanisms, associations and pathology: II. a hypothesis and program for research. Arch. Neurol., 1985b, 42: 521–552.
Hart Y.M., Sander J.W.A.S., Jonson A.L., Shorvon S.D.: National general practice study of epilepsy: recurrence after a first seizure. Lancet, 1990, 336: 1271–1274.
Hauser W.A., Rich S.S., Annegers J.F., Anderson V.E.: Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology, 1990, 40: 1163–1170.
Hauser W.A., Rich S.S., Lee J.R., Annegers J.F. Anderson V.E.: Risk of recurrent seizures after two unprovoked seizures. N. Engl. J. Med., 1998, 338: 429–434.
Kulynych J.J. Vladar K., Jones D.W., Weinberger D.R.: Gender Differences in the Normal Lateralization of the Supratemporal Cortex: MRI Surface-rendering Morphometry of Heschl’s Gyrus and the Planum Temporale. Cerebral cortex, 1994, 4: 107–118.
Kwan P. and Brodie M.J.: Early identification of refractory epilepsy. N. Engl. J. Med., 2000, 342: 314–319.
Löscher W.: Current knowledge on basic mechanisms of drugresistance. In: P. Kahane, A. Berg, W. Lőscher, D. Nordli, E. Perucca (eds), Drug-resistant epilepsies, John Libbey Eurotext, Motrouge 2008, 47–61.
Löscher W.: Mechanisms of drug resistance. Epileptic Disord., 2005, 7 (Suppl. 1): 3–9.
Mathews D.E., Farewell V.T.: Using and Understanding Medical Statistics. Karger, Basel 2007, 322.
Mattson R.H. Cramer J.A., Collins J.F.: The Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Prognosis for total control of complex partial and secondarily generalized tonic-clonic seizures. Neurology, 1996, 47: 68–76.
Miller J.W., Jayadev S., Dodrill C.B., Ojemann G.A.: Gender differences in handedness and speech lateralization related to early neurologic insults. Neurology, 2005, 65: 1974–1975.
Perucca E.: Can drug resistance in epilepsy be minimized? Challenging commonly held beliefs. Epileptic Disord., 2005, 7 (Suppl. 1): 14–21.
Sander J.W.A.S.: Some aspects of prognosis in the epilepsies: a review. Epilepsia, 1993, 34: 1007–10016.
Schmidt D. and Löscher W.: Drug resistance in epilepsy: putative neurobiological and clinical mechanisms. Epilepsia, 2005, 46: 858–877.
Semah F. and Ryvlin P.: Can we predict refractory epilepsy at the time of diagnosis? Epileptic Disord., 2005, 7 (Suppl. 1): 10–13.
Semah F., Picot M.C., Adam C., Broglin D., Arzimanoglou A., Bazin B., Cavalcanti D., Baulac M.: Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology, 1998, 51: 1256–1262.